Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis von Weitz, Jeffrey I., Segers, Annelise, Raskob, Gary, Roberts, Robin S., Francis, Charles, Lassen, Michael Rud, Fuji, Takeshi, Swaim, Renée M., Lee, Michael, Peters, Gary, DiBattiste, Peter M., Tesfaye, Fisseha, Strony, John

Volltext